Acetate drives ovarian cancer quiescence via ACSS2-mediated acetyl-CoA production
Allison C. Sharrow, Emily Megill, Amanda J Chen, Afifa Farooqi, Naveen Kumar Tangudu, Apoorva Uboveja, Stacy C. McGonigal, Nadine Hempel, Nathaniel W. Snyder, Ronald J. Buckanovich, Katherine M. Aird
This study shows that ACSS2-mediated acetate conversion to acetyl-CoA promotes quiescence in ovarian cancer cells, linking metabolic reprogramming to therapeutic resistance.
Molecular Metabolism · Sep 19, 2024Peer-reviewedCancer Biology